Edition:
United States

Boule Diagnostics AB (BOUL.ST)

BOUL.ST on Stockholm Stock Exchange

86.00SEK
25 May 2016
Change (% chg)

-- (--)
Prev Close
86.00kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,441
52-wk High
102.00kr
52-wk Low
62.50kr

BOUL.ST

Chart for BOUL.ST

About

Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that... (more)
No analyst recommendations are available for BOUL.ST.

Overall

Beta: 0.82
Market Cap(Mil.): kr404.81
Shares Outstanding(Mil.): 4.71
Dividend: 0.60
Yield (%): 0.70

Financials

  BOUL.ST Industry Sector
P/E (TTM): 26.47 28.61 35.45
EPS (TTM): 3.25 -- --
ROI: 7.93 8.68 13.24
ROE: 8.56 13.27 14.46

BRIEF-Boule Diagnostics Q1 operating profit down at SEK 8.4 million

* Q1 net sales 84.4 million Swedish crowns ($10.34 million) versus 75.3 million crowns year ago

May 12 2016

BRIEF-Boule Diagnostics wins contract in India

* Instruments will be installed in 136 hospitals in H2 2016 Source text: http://bit.ly/1TyLCYa Further company coverage: (Gdynia Newsroom)

May 10 2016

BRIEF-Boule Diagnostics Q4 oper profit falls to SEK 0.6 million

* Q4 net sales 88.4 million Swedish crowns versus 90.1 million crowns year ago

Feb 18 2016

BRIEF-Boule Diagnostics names Peter von Ehrenheim new chairman

Jan 26 Boule Diagnostics AB : * Chairman Lars-Olof Gustavsson leaves board * Peter von Ehrenheim chosen as new Chairman Source text: bit.ly/1OUH5h3 Further company coverage: (Gdynia Newsroom)

Jan 26 2016

BRIEF-Boule Diagnostics signs distribution deal in USA

* Signs distribution deal in USA with Medica Corporation Inc.

Jan 18 2016

BRIEF-Svolder, Nordea Fonder and Grenspecialisten buy shares in Boule Diagnostics

* Svolder AB, Nordea Fonder and AB Grenspecialisten have bought 11.6 percent, 11.6 percent 10.2 percent respectively of shares in the company

Dec 16 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Reuters Investment Profile
$20.00
Provider : Sadif Analytics Prime
$10.00
Provider : Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.